Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Interferon lambda-1 (IFNL1) binds Interleukin-10 receptor su...
| Class:Id | Summation:448606 |
|---|---|
| _displayName | Interferon lambda-1 (IFNL1) binds Interleukin-10 receptor su... |
| _timestamp | 2017-07-04 12:28:56 |
| created | [InstanceEdit:448563] Jupe, S, 2009-11-25 |
| literatureReference | [LiteratureReference:8987128] Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling (Dumoutier et al. ). [LiteratureReference:9005389] The structure of human interferon lambda and what it has taught us [LiteratureReference:9011684] IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex [LiteratureReference:448607] IL-28, IL-29 and their class II cytokine receptor IL-28R |
| modified | [InstanceEdit:6787824] Jupe, Steve, 2015-07-17 [InstanceEdit:6801261] Garapati, Phani Vijay, 2015-10-01 [InstanceEdit:6804715] Jupe, Steve, 2015-10-14 [InstanceEdit:8850923] Jupe, Steve, 2016-01-04 [InstanceEdit:8854660] Jupe, Steve, 2016-01-28 [InstanceEdit:8987431] Duenas, Corina, 2017-05-05 [InstanceEdit:9005492] Duenas, Corina, 2017-05-09 [InstanceEdit:9006768] Duenas, Corina, 2017-05-19 [InstanceEdit:9009222] Duenas, Corina, 2017-06-16 [InstanceEdit:9009474] Duenas, Corina, 2017-06-19 [InstanceEdit:9010848] Duenas, Corina, 2017-06-28 [InstanceEdit:9010942] Duenas, Corina, 2017-06-28 [InstanceEdit:9011073] Duenas, Corina, 2017-06-29 [InstanceEdit:9011370] Jupe, Steve, 2017-06-30 [InstanceEdit:9011691] Duenas, Corina, 2017-07-04 |
| text | Interferon lambda-1 (IFNL1) binds Interleukin-10 receptor subunit beta (IL10RB), which is associated with Non-receptor tyrosine-protein kinase TYK2 (TYK2), and Interferon lambda receptor-1 (IFNLR1), which is associated with Tyrosine-protein kinase JAK1 (JAK1). Interferon lambda-2 (IFNL2, IL28A), Interleukin-28B (IL28B, Interferon lambda-3) and Interferon lambda-1 (IFNL1, Interleukin-29) are related cytokines, collectively known as the type III interferons. They are distantly related to the type I interferons (IFNs) and are members of the class II cytokine family, which includes type I, II, and III interferons and the Interleukin-10 family (IL10, Interleukin-19 (IL19), Interleukin-20 (IL20), Interleukin-22 (IL22), Interleukin-24 (IL24), and Interleukin-26 (IL26)). They are encoded by genes that form a cluster on 19q13. Expression of all three IFNLs can be induced by viral infection. They share a heterodimeric class II cytokine receptor that consists of IFNLR1 and interleukin-10 receptor beta (IL10RB) (Kotenko et al. 2003, Sheppard et al. 2003). IL10RB is also part of the receptor complexes for IL10, IL22, IL24 and IL26. IFNL1, IFNL2 and IFNL3, like type I IFNs, can signal through ISRE regulatory sites and are likely to provide antiviral activity by the induction of at least a subset of IFN-stimulated genes (Dumoutier et al. 2004, Gad et al 2004, Sheppard et al. 2003). |
| (summation) | [Reaction:448661] IFNL1 binds IL10RB:TYK2 and IFNLR1:JAK1 [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by Interferon lambda-1 (IFNL1) binds Interleukin-10 receptor su... (448606)
